Insider trading

Period: 120 months Stock: XENE Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

56 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

56 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

56 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

56 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
56 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
56 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

56 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Mar 2023
Sold, plan not stated 2×
$711.20K 19,232 at 36.98
36.1%
25 Nov 2022
PATOU GARY Director
Sold, plan not stated
$67.39K 1,937 at 34.79
7.6%
23 Nov 2022
PATOU GARY Director
Sold, plan not stated
$70.61K 2,057 at 34.33
8.0%
2 Sep 2022
AULIN SHERRY Chief Financial Officer
Sold, plan not stated
$607.60K 15,355 at 39.57
100%
Sold half or more
1 Sep 2022
ROBIN SHERRINGTON EVP, Strategy & Innovation
Sold, plan not stated 2×
$1.68M 43,879 at 38.18
72.3%
Sold half or more
31 Aug 2022
ROBIN SHERRINGTON EVP, Strategy & Innovation
Sold, plan not stated
$823.55K 21,352 at 38.57
56.0%
Sold half or more
16 Aug 2022
Sold, plan not stated 2×
$2.00M 52,058 at 38.51
89.7%
Sold half or more
15 Aug 2022
Sold, plan not stated
$1.28M 33,942 at 37.76
36.9%
12 Aug 2022
Sold, plan not stated 3×
$3.49M 91,135 at 38.28
49.8%
12 Aug 2022
EMPFIELD JAMES R. EVP, Drug Discovery
Sold, plan not stated 2×
$2.21M 57,743 at 38.31
85.2%
Sold half or more
8 Mar 2022
Sold, plan not stated 6×
$375.64K 14,551 at 25.82
7.4%
7 Mar 2022
EMPFIELD JAMES R. EVP, Drug Discovery
Sold, plan not stated 2×
$1.00M 32,853 at 30.54
76.7%
Sold half or more
7 Mar 2022
Sold, plan not stated 7×
$948.26K 31,086 at 30.50
13.6%
4 Mar 2022
ROBIN SHERRINGTON EVP, Strategy & Innovation
Sold, plan not stated 4×
$662.21K 21,710 at 30.50
55.7%
Sold half or more
4 Mar 2022
EMPFIELD JAMES R. EVP, Drug Discovery
Sold, plan not stated
$563.92K 18,315 at 30.79
64.7%
Sold half or more
4 Mar 2022
Sold, plan not stated 2×
$285.43K 9,325 at 30.61
4.2%
21 Jan 2022
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Bought
$20.17K 700 at 28.81
opened
First buy on file
6 Dec 2021
Von Seggern Christopher Chief Commercial Officer
Bought
$97.60K 4,000 at 24.40
opened
First buy on file
15 Nov 2021
Sold, plan not stated
$550.06K 17,557 at 31.33
7.7%
28 May 2021
ROBIN SHERRINGTON EVP, Strategy & Innovation
Sold, plan not stated 2×
$114.12K 6,067 at 18.81
15.8%
27 May 2021
HOLLER FRANK A Director
Sold, plan not stated 2×
$206.70K 11,064 at 18.68
7.2%
1 Jun 2020
Sold, plan not stated
$43.29K 3,000 at 14.43
1.2%
29 May 2020
Sold, plan not stated
$69.95K 5,000 at 13.99
1.9%
20 Sep 2019
Sold, plan not stated
$98.86K 10,395 at 9.51
3.9%
20 Sep 2019
HOLLER FRANK A Director
Sold, plan not stated
$48.88K 5,206 at 9.39
4.2%
19 Sep 2019
HOLLER FRANK A Director
Sold, plan not stated
$70.45K 7,600 at 9.27
5.8%
18 Sep 2019
HOLLER FRANK A Director
Sold, plan not stated
$40.54K 4,368 at 9.28
3.2%
17 Sep 2019
HOLLER FRANK A Director
Sold, plan not stated
$47.24K 5,069 at 9.32
3.6%
13 Sep 2019
AZAB MOHAMMAD Director
Sold, plan not stated
$214.18 23 at 9.31
0.0%
15 Nov 2017
AZAB MOHAMMAD Director
Bought
$33.28K 15,000 at 2.22
51.4%
First buy on file
22 Sep 2017
AZAB MOHAMMAD Director
Bought
$23.60K 8,000 at 2.95
37.7%
First buy on file
21 Sep 2017
AZAB MOHAMMAD Director
Bought
$5.90K 2,000 at 2.95
10.4%
First buy on file
18 Aug 2017
AZAB MOHAMMAD Director
Bought
$18.30K 6,312 at 2.90
48.9%
First buy on file
18 Aug 2017
WINQUIST RAYMOND Head, Translational Research
Bought
$3.00K 1,000 at 3.00
opened
First buy on file
17 Aug 2017
AZAB MOHAMMAD Director
Bought
$60.95 23 at 2.65
0.2%
First buy on file
15 Aug 2017
Bought 2×
$45.49K 18,858 at 2.41
1.1%
First buy on file
15 Aug 2017
EMPFIELD JAMES R. SVP, Drug Discovery
Bought
$24.82K 10,000 at 2.48
opened
First buy on file
14 Aug 2017
Svoronos Dawn Director
Bought
$140.77K 50,000 at 2.82
opened
First buy on file
14 Aug 2017
Bought 2×
$111.78K 41,344 at 2.70
2.5%
First buy on file
14 Aug 2017
Hayden Michael R Director
Bought
$41.25K 15,000 at 2.75
10.3%
First buy on file
11 Aug 2017
GANNON STEVEN Director
Bought
$42.27K 15,000 at 2.82
opened
First buy on file
10 Aug 2017
MORTIMER IAN CFO & COO · indirect
Bought
$29.00K 10,000 at 2.90
233%
First buy on file
10 Aug 2017
PATOU GARY Director · indirect
Bought
$20.84K 7,500 at 2.78
150%
First buy on file
10 Aug 2017
Bought
$19.95K 7,000 at 2.85
opened
First buy on file
10 Aug 2017
PIMSTONE SIMON N. President & CEO
Bought
$17.40K 6,000 at 2.90
2.8%
First buy on file
10 Aug 2017
MORTIMER IAN CFO & COO
Bought
$14.23K 5,000 at 2.85
500%
First buy on file
8 Aug 2017
PATOU GARY Director · indirect
Bought
$15.00K 5,000 at 3.00
opened
First buy on file
27 Jun 2017
Bought 3×
$341.84K 85,461 at 4.00
5.5%
First buy on file
22 Jun 2017
Bought 3×
$33.05K 8,263 at 4.00
0.5%
First buy on file
21 Jun 2017
Bought 3×
$48.59K 12,148 at 4.00
0.8%
First buy on file
Showing 1–50 of 56. Page 1 of 2 Older →